Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 known ✓ | P03372 | 2/20 | 0.35 |
| ▸ | ESR2 known ✓ | Q92731 | 2/20 | 0.35 |
| ▸ | KCNN4 | O15554 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28904471 | 1.00 | KCNN4 (0.45) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 | |
| Hydrochloric Acid SCHEMBL28904470 | 1.00 | KCNN4 (0.45) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 | |
| SCHEMBL416260 | 0.97 | KCNN4 (0.47) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 | |
| SCHEMBL30581193 | 0.93 | KCNN4 (0.45) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 | |
| Iodide SCHEMBL114296 | 0.93 | KCNN4 (0.45) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 | |
| Fluoride SCHEMBL28904466 | 0.93 | KCNN4 (0.45) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 | |
| Bromide SCHEMBL102597 | 0.93 | KCNN4 (0.45) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 | |
| Fluoride SCHEMBL8188285 | 0.93 | KCNN4 (0.45) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 | |
| Fluoride SCHEMBL28904468 | 0.93 | KCNN4 (0.45) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 | |
| SCHEMBL27785755 | 0.93 | KCNN4 (0.45) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 416 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122079956-A | Preparation method of heterocyclic compound | — | 2026-05-26 | — | — | CN | claimed |
| CN-118932196-A | Method for separating rhenium and molybdenum by utilizing quaternary phosphonium salt modified material | 武汉轻工大学 | 2024-11-12 | — | — | CN | claimed |
| CN-115806569-A | High-temperature-resistant quaternary phosphonium sulfonate organic antibacterial flame-retardant monomer for polyester polymerization, and preparation method and application thereof | 浙江恒逸石化研究院有限公司 | 2023-03-17 | — | — | CN | claimed |
| EP-2951140-B1 | PROCESS FOR THE PREPARATION OF 1-CHLORO-3,3,3-TRIFLUOROPROPENE USING A PHASE TRANSFER CATALYST | HONEYWELL INT INC (US) | 2018-01-10 | — | — | EP | claimed |
| US-9522915-B2 | Method for preparing an important intermediate of linagliptin | 2Y-CHEM, LTD. (CN) | 2016-12-20 | — | — | US | claimed |
| WO-2016147132-A1 | A PROCESS FOR THE PREPARATION OF DROXIDOPA | Piramal Enterprises Limited (IN) | 2016-09-22 | — | — | WO | claimed |
| WO-2016147133-A1 | PROCESS FOR THE PREPARATION OF DROXIDOPA | Piramal Enterprises Limited (IN) | 2016-09-22 | — | — | WO | claimed |
| EP-2951140-A1 | PROCESS FOR THE PREPARATION OF 1-CHLORO-3,3,3-TRIFLUOROPROPENE USING A PHASE TRANSFER CATALYST | Honeywell International Inc. (US) | 2015-12-09 | — | — | EP | claimed |
| US-20150274728-A1 | METHOD FOR PREPARING AN IMPORTANT INTERMEDIATE OF LINAGLIPTIN | 2Y-CHEM, LTD. (CN) | 2015-10-01 | — | — | US | claimed |
| US-9006447-B2 | Method for preparing substituted isoxazoline compounds and their precursors 4-chloro, 4-bromo- or 4-iodobenzaldehyde oximes | BASF SE (DE) | 2015-04-14 | — | — | US | claimed |
| US-20140221704-A1 | PROCESS FOR THE PREPARATION OF 1-CHLORO-3,3,3-TRIFLUOROPROPENE USING A PHASE TRANSFER CATALYST | HONEYWELL INTERNATIONAL INC. (US) | 2014-08-07 | — | — | US | claimed |
| WO-2014121171-A1 | PROCESS FOR THE PREPARATION OF 1-CHLORO-3,3,3-TRIFLUOROPROPENE USING A PHASE TRANSFER CATALYST | HONEYWELL INTERNATIONAL INC. (US) | 2014-08-07 | — | — | WO | claimed |
| EP-2635552-A2 | METHOD FOR PREPARING SUBSTITUTED ISOXAZOLINE COMPOUNDS AND THEIR PRECURSORS 4-CHLORO, 4-BROMO- OR 4-IODOBENZALDEHYDE OXIMES | BASF SE (DE) | 2013-09-11 | — | — | EP | claimed |
| US-20130225826-A1 | Method for preparing substituted isoxazoline compounds and their precursors 4-chloro, 4-bromo- or 4-iodobenzaldehyde oximes | BASF SE (DE) | 2013-08-29 | — | — | US | claimed |
| WO-2012059441-A2 | METHOD FOR PREPARING SUBSTITUTED ISOXAZOLINE COMPOUNDS AND THEIR PRECURSORS 4-CHLORO, 4-BROMO- OR 4-IODOBENZALDEHYDE OXIMES | BASF SE (DE) | 2012-05-10 | — | — | WO | claimed |
| US-20120059171-A1 | Process for Preparing Substituted Isoxazoline Compounds and Their Precursors | BASF SE (DE) | 2012-03-08 | — | — | US | claimed |
| EP-2424862-A1 | PROCESS FOR PREPARING SUBSTITUTED ISOXAZOLINE COMPOUNDS AND THEIR PRECURSORS | BASF SE (DE) | 2012-03-07 | — | — | EP | claimed |
| WO-2010125130-A1 | PROCESS FOR PREPARING SUBSTITUTED ISOXAZOLINE COMPOUNDS AND THEIR PRECURSORS | BASF SE (DE) | 2010-11-04 | — | — | WO | claimed |
| US-4831166-A | REACTING ALKYLENE OXIDE WITH ACYLACETATE USING IONIC HALIDE CATALYST | BASF AKTIENGESELLSCHAFT (DE) | 1989-05-16 | — | — | US | claimed |
| US-4810808-A | Process for preparing polyglycidyl compounds | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1989-03-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150274728-A1 | METHOD FOR PREPARING AN IMPORTANT INTERMEDIATE OF LINAGLIPTIN | DPP4, DPP9, DPP3 | ESR1 3778/4885ESR2 4202/4885KCNN4 2399/4885 |
| US-20130225826-A1 | Method for preparing substituted isoxazoline compounds and their precursors 4-chloro, 4-bromo- or 4-iodobenzaldehyde oximes | CYP4X1, CYP4B1, AOX1 | ESR1 3703/4885ESR2 3406/4885KCNN4 682/4885 |
| US-20120059171-A1 | Process for Preparing Substituted Isoxazoline Compounds and Their Precursors | CYP4X1, CYP3A7, CYP1B1 | ESR1 2232/4885ESR2 2538/4885KCNN4 2657/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.